Literature DB >> 6812758

Retroperitoneal fibrosis associated with sotalol.

M Laakso, I Arvala, S Tervonen, M Sotarauta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812758      PMCID: PMC1500030          DOI: 10.1136/bmj.285.6348.1085-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS.

Authors:  J R GRAHAM
Journal:  N Engl J Med       Date:  1964-01-09       Impact factor: 91.245

2.  Retroperitoneal fibrosis associated with metoprolol.

Authors:  J Thompson; D G Julian
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

3.  Oxprenolol and retroperitoneal fibrosis.

Authors:  D R McClusky; R A Donaldson; M G McGeown
Journal:  Br Med J       Date:  1980-11-29
  3 in total
  6 in total

Review 1.  Idiopathic retroperitoneal fibrosis.

Authors:  N Bullock
Journal:  BMJ       Date:  1988-07-23

Review 2.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

Review 3.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

Review 4.  New antiarrhythmic drugs.

Authors:  P F Nestico; J Morganroth; L N Horowitz
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

5.  Do beta-adrenoceptor blocking drugs cause retroperitoneal fibrosis?

Authors:  J P Pryor; W M Castle; D C Dukes; J C Smith; M E Watson; J L Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-03

Review 6.  Drug-induced bladder and urinary disorders. Incidence, prevention and management.

Authors:  M J Drake; P M Nixon; J P Crew
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.